| Bryan Bolinger, DO | |
|
740 High St Ste 3002, Williamsport, PA 17701-3102 | |
| (570) 321-2820 | |
| (570) 321-2821 |
| Full Name | Bryan Bolinger |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 17 Years |
| Location | 740 High St Ste 3002, Williamsport, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609149871 | NPI | - | NPPES |
| 102937048 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | OS016949 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Pinnacle Health Hospitals | Harrisburg, PA | Hospital |
| Upmc Pinnacle Hanover | Hanover, PA | Hospital |
| Upmc Memorial | York, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pinnacle Health Medical Services | 7618960493 | 942 |
News Archive
A concussion should not only take a student athlete off the playing field - it may also require a break from the classroom, according to a new clinical report from the American Academy of Pediatrics.
A new clinical trial designed to study how worm eggs may relieve symptoms of ulcerative colitis (UC) will begin enrolling patients at NYU School of Medicine's Clinical and Translational Science Institute. This unusual therapy has been used in previous clinical trials on patients with inflammatory bowel diseases, but the mechanism of action is unclear.
BioMimetic Therapeutics, Inc. today announced that it has received orphan drug designation from the Food and Drug Administration for its protein therapeutic, recombinant human platelet derived growth factor, to be used in conjunction with autograft and/or commercially available osteochondral allograft for the treatment of osteochondritis dissecans of the knee, elbow or ankle.
September is Muscular Dystrophy Awareness Month. There are more than 100 neuromuscular disorders and it is estimated more than 50,000 Canadians are affected by one form or another. Each form is caused by an error in a specific gene related to muscle function.
› Verified 4 days ago
| Entity Name | Upmc Altoona Regional Health Services, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396724217 PECOS PAC ID: 5395659312 Enrollment ID: O20040312000257 |
News Archive
A concussion should not only take a student athlete off the playing field - it may also require a break from the classroom, according to a new clinical report from the American Academy of Pediatrics.
A new clinical trial designed to study how worm eggs may relieve symptoms of ulcerative colitis (UC) will begin enrolling patients at NYU School of Medicine's Clinical and Translational Science Institute. This unusual therapy has been used in previous clinical trials on patients with inflammatory bowel diseases, but the mechanism of action is unclear.
BioMimetic Therapeutics, Inc. today announced that it has received orphan drug designation from the Food and Drug Administration for its protein therapeutic, recombinant human platelet derived growth factor, to be used in conjunction with autograft and/or commercially available osteochondral allograft for the treatment of osteochondritis dissecans of the knee, elbow or ankle.
September is Muscular Dystrophy Awareness Month. There are more than 100 neuromuscular disorders and it is estimated more than 50,000 Canadians are affected by one form or another. Each form is caused by an error in a specific gene related to muscle function.
› Verified 4 days ago
| Entity Name | Pinnacle Health Medical Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932143427 PECOS PAC ID: 7618960493 Enrollment ID: O20040407000180 |
News Archive
A concussion should not only take a student athlete off the playing field - it may also require a break from the classroom, according to a new clinical report from the American Academy of Pediatrics.
A new clinical trial designed to study how worm eggs may relieve symptoms of ulcerative colitis (UC) will begin enrolling patients at NYU School of Medicine's Clinical and Translational Science Institute. This unusual therapy has been used in previous clinical trials on patients with inflammatory bowel diseases, but the mechanism of action is unclear.
BioMimetic Therapeutics, Inc. today announced that it has received orphan drug designation from the Food and Drug Administration for its protein therapeutic, recombinant human platelet derived growth factor, to be used in conjunction with autograft and/or commercially available osteochondral allograft for the treatment of osteochondritis dissecans of the knee, elbow or ankle.
September is Muscular Dystrophy Awareness Month. There are more than 100 neuromuscular disorders and it is estimated more than 50,000 Canadians are affected by one form or another. Each form is caused by an error in a specific gene related to muscle function.
› Verified 4 days ago
| Entity Name | Susquehanna Physician Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629006606 PECOS PAC ID: 2264336460 Enrollment ID: O20040702000607 |
News Archive
A concussion should not only take a student athlete off the playing field - it may also require a break from the classroom, according to a new clinical report from the American Academy of Pediatrics.
A new clinical trial designed to study how worm eggs may relieve symptoms of ulcerative colitis (UC) will begin enrolling patients at NYU School of Medicine's Clinical and Translational Science Institute. This unusual therapy has been used in previous clinical trials on patients with inflammatory bowel diseases, but the mechanism of action is unclear.
BioMimetic Therapeutics, Inc. today announced that it has received orphan drug designation from the Food and Drug Administration for its protein therapeutic, recombinant human platelet derived growth factor, to be used in conjunction with autograft and/or commercially available osteochondral allograft for the treatment of osteochondritis dissecans of the knee, elbow or ankle.
September is Muscular Dystrophy Awareness Month. There are more than 100 neuromuscular disorders and it is estimated more than 50,000 Canadians are affected by one form or another. Each form is caused by an error in a specific gene related to muscle function.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bryan Bolinger, DO 2005 Technology Pkwy Ste 400, Mechanicsburg, PA 17050-9413 Ph: () - | Bryan Bolinger, DO 740 High St Ste 3002, Williamsport, PA 17701-3102 Ph: (570) 321-2820 |
News Archive
A concussion should not only take a student athlete off the playing field - it may also require a break from the classroom, according to a new clinical report from the American Academy of Pediatrics.
A new clinical trial designed to study how worm eggs may relieve symptoms of ulcerative colitis (UC) will begin enrolling patients at NYU School of Medicine's Clinical and Translational Science Institute. This unusual therapy has been used in previous clinical trials on patients with inflammatory bowel diseases, but the mechanism of action is unclear.
BioMimetic Therapeutics, Inc. today announced that it has received orphan drug designation from the Food and Drug Administration for its protein therapeutic, recombinant human platelet derived growth factor, to be used in conjunction with autograft and/or commercially available osteochondral allograft for the treatment of osteochondritis dissecans of the knee, elbow or ankle.
September is Muscular Dystrophy Awareness Month. There are more than 100 neuromuscular disorders and it is estimated more than 50,000 Canadians are affected by one form or another. Each form is caused by an error in a specific gene related to muscle function.
› Verified 4 days ago
Fadi Sweiss, Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 740 High St Ste 3002, Suite 3002, Williamsport, PA 17701 Phone: 570-321-2820 | |
Kerry Vaughan, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 740 High St Ste 3002, Williamsport, PA 17701 Phone: 570-321-2820 | |
Dr. Wenzhuan He, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 740 High St Ste 3002, Williamsport, PA 17701 Phone: 570-321-2820 Fax: 570-321-2821 | |
Dr. Philip Joseph Hlavac, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 740 High St Ste 3002, Williamsport, PA 17701 Phone: 570-321-2820 Fax: 570-321-2821 | |
Jonathan Bussey, Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 740 High St Ste 3002, Suite 3002, Williamsport, PA 17701 Phone: 570-321-2820 | |
Dr. Hani Jawdat Tuffaha, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 740 High St Ste 3002, Williamsport, PA 17701 Phone: 570-321-2820 Fax: 570-321-2821 |